X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3288) 3288
Book Review (549) 549
Publication (317) 317
Newsletter (163) 163
Conference Proceeding (25) 25
Newspaper Article (20) 20
Book Chapter (16) 16
Magazine Article (11) 11
Dissertation (3) 3
Trade Publication Article (2) 2
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2341) 2341
fingolimod (1625) 1625
humans (1608) 1608
multiple sclerosis (1436) 1436
sphingosine - analogs & derivatives (1375) 1375
fingolimod hydrochloride (1321) 1321
animals (1180) 1180
fty720 (925) 925
male (835) 835
clinical neurology (767) 767
female (757) 757
immunosuppressive agents - therapeutic use (733) 733
propylene glycols - pharmacology (668) 668
oral fingolimod (636) 636
mice (613) 613
immunosuppressive agents - pharmacology (556) 556
propylene glycols - therapeutic use (551) 551
sphingosine - pharmacology (536) 536
neurosciences (519) 519
multiple sclerosis - drug therapy (473) 473
immunology (463) 463
adult (461) 461
pharmacology & pharmacy (453) 453
sphingosine - therapeutic use (417) 417
rats (412) 412
sphingosine 1-phosphate (395) 395
multiple sclerosis, relapsing-remitting - drug therapy (386) 386
natalizumab (383) 383
sphingosine-1-phosphate (364) 364
middle aged (354) 354
research (343) 343
neurology (339) 339
sphingosine (327) 327
multiple-sclerosis (313) 313
fingolimod hydrochloride - therapeutic use (308) 308
drug therapy (286) 286
placebo-controlled trial (286) 286
immunosuppressive agents - adverse effects (285) 285
treatment outcome (277) 277
receptors, lysosphingolipid - metabolism (275) 275
mice, inbred c57bl (265) 265
analysis (264) 264
transplantation (262) 262
relapsing multiple-sclerosis (259) 259
phosphates (256) 256
care and treatment (246) 246
double-blind (241) 241
immunosuppressive agents - administration & dosage (236) 236
disease models, animal (230) 230
fingolimod hydrochloride - pharmacology (226) 226
abridged index medicus (223) 223
inflammation (222) 222
interferon (221) 221
lymphocytes (221) 221
experimental autoimmune encephalomyelitis (214) 214
surgery (210) 210
propylene glycols - administration & dosage (206) 206
glatiramer acetate (204) 204
magnetic resonance imaging (203) 203
apoptosis (201) 201
medical research (188) 188
therapy (188) 188
article (186) 186
sphingosine - metabolism (183) 183
administration, oral (174) 174
sphingosine - administration & dosage (172) 172
central-nervous-system (170) 170
health aspects (170) 170
lymphocyte egress (169) 169
immunosuppressant (168) 168
propylene glycols - adverse effects (165) 165
dosage and administration (164) 164
time factors (164) 164
safety (162) 162
activation (160) 160
young adult (159) 159
biochemistry & molecular biology (158) 158
cell biology (156) 156
clinical trials (156) 156
efficacy (156) 156
in-vivo (156) 156
lysophospholipids - metabolism (152) 152
sphingosine - adverse effects (151) 151
expression (150) 150
t-cells (150) 150
progressive multifocal leukoencephalopathy (148) 148
patients (147) 147
medicine, experimental (146) 146
dose-response relationship, drug (145) 145
receptors, lysosphingolipid - agonists (145) 145
fingolimod hydrochloride - adverse effects (143) 143
immunologic factors - therapeutic use (139) 139
cells, cultured (138) 138
apoptosis - drug effects (136) 136
phosphorylation (136) 136
fingolimod fty720 (135) 135
cells (133) 133
circulating mature lymphocytes (133) 133
disease progression (128) 128
medicine & public health (126) 126
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3240) 3240
German (70) 70
Spanish (46) 46
Japanese (39) 39
French (36) 36
Chinese (20) 20
Hungarian (13) 13
Russian (11) 11
Portuguese (8) 8
Czech (7) 7
Polish (4) 4
Finnish (3) 3
Turkish (3) 3
Italian (2) 2
Persian (2) 2
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 03/2016, Volume 133, Issue 10, pp. 954 - 966
Journal Article
NEUROLOGY, ISSN 0028-3878, 03/2019, Volume 92, Issue 10, pp. 451 - 452
Objective: To test blood and CSF neurofilament light chain (NfL) levels in relation to disease progression and survival in amyotrophic lateral sclerosis (ALS).... 
ORAL FINGOLIMOD | CLINICAL NEUROLOGY
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 6, pp. 545 - 556
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 2012, Volume 256, Issue 1, pp. 13 - 18
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 11, pp. 1017 - 1027
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2017, Volume 114, Issue 8, pp. 2012 - 2017
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the CNS that causes disability in young adults as a result of the irreversible... 
Eae | Multiple sclerosis | Astrocytes | Sphingolipid metabolism | Secondary progression | FTY720 FINGOLIMOD | BAF312 SIPONIMOD | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ORAL FINGOLIMOD | multiple sclerosis | MULTIDISCIPLINARY SCIENCES | secondary progression | EAE | sphingolipid metabolism | SLICE CULTURES | IN-VITRO | MULTIPLE-SCLEROSIS | DOUBLE-BLIND | CENTRAL-NERVOUS-SYSTEM | astrocytes | PLACEBO-CONTROLLED TRIAL | Fingolimod Hydrochloride - pharmacology | Microglia - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Monocytes - metabolism | Monocytes - immunology | Female | Sphingosine - metabolism | Receptors, Lysosphingolipid - metabolism | Immunosuppressive Agents - pharmacology | Multiple Sclerosis, Chronic Progressive - drug therapy | Fingolimod Hydrochloride - therapeutic use | Astrocytes - drug effects | Encephalomyelitis, Autoimmune, Experimental - pathology | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Mice, Inbred C57BL | Multiple Sclerosis, Chronic Progressive - pathology | Transcriptome - drug effects | Disease Progression | Animals | Cell Line, Tumor | Mice, Inbred NOD | Mice | Primary Cell Culture | Astrocytes - metabolism | Physiological aspects | Sphingolipids | Health aspects | Neurology | Genomes | Neurodegeneration | Pathogenesis | Genomics | Index Medicus | Biological Sciences
Journal Article
Journal Article
Journal Article